Authors:
Schwenger, V
Mussig, C
Hergesell, O
Zeier, M
Ritz, E
Citation: V. Schwenger et al., Incidence and clinical presentation of terminal renal failure in diabetic patients, DEUT MED WO, 126(47), 2001, pp. 1322-1326
Authors:
Raml, A
Schmekal, B
Grafinger, P
Biesenbach, G
Citation: A. Raml et al., Risk for hyperkalaemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the GFR, DEUT MED WO, 126(47), 2001, pp. 1327-1330
Citation: B. Hammer et al., Fatal allopurinol-induced hypersensitivity syndrome in asymptomatic hyperuricaemia, DEUT MED WO, 126(47), 2001, pp. 1331-1334
Authors:
Mengden, T
Un, S
Tissler, A
Dusing, R
Vetter, H
Illyes, M
Citation: T. Mengden et al., The virtual hypertension clinic: telemedicine in the management of arterial hypertension, DEUT MED WO, 126(47), 2001, pp. 1335-1341
Citation: R. Kolloch et E. Offers, Vasopeptidase inhibition, a new pharmacological principle in the treatmentof hypertension and heart failure, DEUT MED WO, 126(47), 2001, pp. 1342-1347
Citation: S. Buxbaum et al., Epidemiological analysis of immunity against vaccine-preventable diseases:rubella, measles, mumps and varicella zoster virus, DEUT MED WO, 126(46), 2001, pp. 1289-1293